Eden Research Plc

  • Market Cap: Micro Cap
  • Industry: Chemicals & Petrochemicals
  • ISIN: GB0001646941
GBP
0.03
-0.01 (-18.42%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Negative results in Jun 25

  • NET SALES(Q) At GBP 1.2 MM has Fallen at -36.45%
  • INTEREST(HY) At GBP 0.01 MM has Grown at 33.52%
  • OPERATING PROFIT(Q) Lowest at GBP -1.18 MM
2

Risky -

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Chemicals & Petrochemicals

stock-summary
Market cap

GBP 19 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.16

stock-summary
Return on Equity

-22.17%

stock-summary
Price to Book

1.83

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.02%
0%
-4.02%
6 Months
-19.48%
0%
-19.48%
1 Year
-28.74%
0%
-28.74%
2 Years
-38.0%
0%
-38.0%
3 Years
-27.91%
0%
-27.91%
4 Years
-73.04%
0%
-73.04%
5 Years
-60.61%
0%
-60.61%

Eden Research Plc for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
11.83%
EBIT Growth (5y)
-11.67%
EBIT to Interest (avg)
-2.42
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.30
Sales to Capital Employed (avg)
0.22
Tax Ratio
12.23%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.71
EV to EBIT
-6.48
EV to EBITDA
-9.55
EV to Capital Employed
1.85
EV to Sales
4.54
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-28.59%
ROE (Latest)
-22.17%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Eden Research Plc"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 34.37% vs 77.78% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 70.77% vs -195.45% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.30",
          "val2": "3.20",
          "chgp": "34.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.60",
          "val2": "-1.30",
          "chgp": "-23.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-5.00",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.90",
          "val2": "-6.50",
          "chgp": "70.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-513.00%",
          "val2": "-591.30%",
          "chgp": "7.83%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
4.30
3.20
34.37%
Operating Profit (PBDIT) excl Other Income
-1.60
-1.30
-23.08%
Interest
0.00
0.00
Exceptional Items
0.00
-5.00
100.00%
Consolidate Net Profit
-1.90
-6.50
70.77%
Operating Profit Margin (Excl OI)
-513.00%
-591.30%
7.83%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 34.37% vs 77.78% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 70.77% vs -195.45% in Dec 2023

stock-summaryCompany CV
About Eden Research Plc stock-summary
stock-summary
Eden Research Plc
Chemicals & Petrochemicals
Eden Research plc is a technology development and commercialization company. The Company focuses on plant protection, animal and human health, and biocides. The Company's segments include Biocides, Human health and Agrochemicals. It offers a range of product categories, such as Foliar Diseases Control, including Botrytis, Botrytis Trail Data and Powdery Mildew; Soil Pest, including Nematodes and New Nematode Data; Protected Glass House Crops, including Spider Mites, Spider Mite Trail Data, Whitefly, Whitefly Trail Data and Powdery Mildew; Vascular Diseases Control, including Esca, Eutypa and Pierce's Diseases, and Post-Harvest Applications. Its encapsulation technology harnesses the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with hydrophobic compounds both natural and synthetic. The technology uses yeast cells to deliver a slow release of natural compounds for agricultural and non-agricultural uses.
Company Coordinates stock-summary
Company Details
Priory Crt, Business Park, 6 Priory Court CIRENCESTER None : GL7 5JB
stock-summary
Tel: 44 1285 359555
stock-summary
Registrar Details